|
What are the current guidelines for environmental risk assessments of ATMPs, particularly those involving GMOs?
|
|
1
|
47
|
September 9, 2024
|
|
What are the current regulatory pathways for ATMPs in the EU and how do they compare with those in the US?
|
|
0
|
34
|
August 30, 2024
|
|
What can medical centres do to anticipate future ATMP therapies, how can they improve their centre readiness?
|
|
0
|
26
|
August 30, 2024
|
|
What regulations and legislation I need to take in to account when registering a radiopharmaceuticals in the EU?
|
|
0
|
33
|
August 28, 2024
|
|
Which medical isotopes are currently used in clinical practice and what are the advantages and disadvantages of the different medical isotopes?
|
|
0
|
30
|
August 28, 2024
|
|
Drug repurposing in rare diseases
|
|
2
|
76
|
August 21, 2024
|